Biotech entrepreneur Jonathan Montagu has joined the board of OMass Therapeutics Ltd as a non-executive director to help guide the company’s drug discovery activities. Founded in 2016, OMass uses structural mass spectrometry to discover new drug compounds. Mr Montagu is the co-founder and chief executive of HotSpot Therapeutics Inc of Boston, US which is developing allosteric medicines for the treatment of autoimmune and metabolic diseases. Prior to this, he was chief business officer at Nimbus Therapeutics Inc and head of business development at Concert Therapeutics Inc.
Mr Montagu received a Masters’ degree in chemistry from the University of Oxford in the UK and a Master of Business Administration degree from the Stanford Graduate School of Business in the US.
OMass Therapeutics announced the appointment on 12 June 2019.
Copyright 2019 Evernow Publishing Ltd.